Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
R127536-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $71.90 | |
R127536-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $221.90 | |
R127536-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $305.90 | |
R127536-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $418.90 | |
R127536-50mg | 50mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $791.90 |
Synonyms | Mericitabine|940908-79-2|R-7128|R7128|PSI 6130 diisobutyrate|RG7128|RO-5024048|RG 7128|3',5'-Diisobutyryl PSI 6130|R 7128|RG-7128|TA63JX8X52|2'-Deoxy-2'-fluoro-2'-C-methylcytidine diisobutyrate|RO5024048|(2R,3R,4R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-4 |
---|---|
Specifications & Purity | ≥98% |
Biochemical and Physiological Mechanisms | R-7128(RG 7128; Mericitabine; PSI 6130 diisobutyrate)is RNA-directed RNA polymerase (NS5B) inhibitor treatment of hepatitis C virus infection. R-7128 (RG 7128; Mericitabine; PSI 6130 diisobutyrate) is useful for antiviral agents |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Action Type | INHIBITOR |
Mechanism of action | Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor |
Product Description |
Mericitabine (RG 7128; R-7128) is a nucleoside inhibitor of the HCV NS5B polymerase that acts as an RNA chain terminator and prevents elongation of RNA transcripts during replication.
|
ALogP | 1.3 |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | [(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-4-fluoro-4-methyl-3-(2-methylpropanoyloxy)oxolan-2-yl]methyl 2-methylpropanoate |
---|---|
INCHI | InChI=1S/C18H26FN3O6/c1-9(2)14(23)26-8-11-13(28-15(24)10(3)4)18(5,19)16(27-11)22-7-6-12(20)21-17(22)25/h6-7,9-11,13,16H,8H2,1-5H3,(H2,20,21,25)/t11-,13-,16-,18-/m1/s1 |
InChi Key | MLESJYFEMSJZLZ-MAAOGQSESA-N |
Canonical SMILES | CC(C)C(=O)OCC1C(C(C(O1)N2C=CC(=NC2=O)N)(C)F)OC(=O)C(C)C |
Isomeric SMILES | CC(C)C(=O)OC[C@@H]1[C@H]([C@@]([C@@H](O1)N2C=CC(=NC2=O)N)(C)F)OC(=O)C(C)C |
PubChem CID | 16122663 |
Molecular Weight | 399.41 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
E2431362 | Certificate of Analysis | Feb 04, 2024 | R127536 |
E2431374 | Certificate of Analysis | Feb 04, 2024 | R127536 |
E2431375 | Certificate of Analysis | Feb 04, 2024 | R127536 |
E2431376 | Certificate of Analysis | Feb 04, 2024 | R127536 |
E2431390 | Certificate of Analysis | Feb 04, 2024 | R127536 |
E2431391 | Certificate of Analysis | Feb 04, 2024 | R127536 |
E2431402 | Certificate of Analysis | Feb 04, 2024 | R127536 |
E2431442 | Certificate of Analysis | Feb 04, 2024 | R127536 |
E2431443 | Certificate of Analysis | Feb 04, 2024 | R127536 |
E2431444 | Certificate of Analysis | Feb 04, 2024 | R127536 |
Solubility | DMSO |
---|
Starting at $1,800.90
Starting at $260.90
Starting at $64.90
Starting at $350.90
Starting at $700.90